Mechanisms of obesity-induced male infertility

Expert Review of Endocrinology and Metabolism

Volumn 5, Issue 2, 2010, Pages 229-251

  Phillips, Karen P ^a   Tanphaichitr, Nongnuj ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Endocrine disrupters; Estrogen; Hypogonadism; Leptin; Obesity; Obesogens; Semen

Indexed keywords

ADIPOCYTOKINE; DIETHYLSTILBESTROL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GONADOTROPIN; HEAT SHOCK PROTEIN 70; KISSPEPTIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TESTIS PEPTIDE HORMONE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; APOPTOSIS; BODY MASS; CELL HYPOXIA; DIABETES MELLITUS; DISEASE ASSOCIATION; EJACULATION DISORDER; ENVIRONMENTAL STRESS; ESTROGEN RELEASE; GONADOTROPIN RELEASE; HEAT STRESS; HORMONE ACTION; HUMAN; HYPOGONADISM; HYPOTHALAMUS; MALE INFERTILITY; MATURITY ONSET DIABETES MELLITUS; METABOLIC SYNDROME X; NONHUMAN; OBESITY; ONSET AGE; PATHOPHYSIOLOGY; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; SPERMATOGENESIS; SPERMATOZOON ABNORMALITY; SPERMATOZOON CAPACITATION; SPERMATOZOON MATURATION; STEROIDOGENESIS; SUBFERTILITY; TESTIS FUNCTION;

EID: 77949593154     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/eem.09.65     Document Type: Review

References (209)

1. Adamson GD, Baker VL. Subfertility: causes, treatment and outcome. Best Pract. Res. Clin. Obstet Gynaecol. 17, 169-185 (2003).
2. Kasturi SS, Tannir J, Brannigan RE. The metabolic syndrome and male infertility. J. Androl. 29, 251-259 (2008).
3. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282, 1519-1522 (1999).
4. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79 (2003).
5. Collins S. Overview of clinical perspectives and mechanisms of obesity. Birth Defects Res. 73, 470-471 (2005).
6. Naz RK, Rajesh PB. Role of tyrosine phosphorylation in sperm capacitation/ acrosome reaction. Reprod. Biol. Endocrinol. 9(2), 75 (2004).
7. Visconte PE. Understanding the molecular basis of sperm capacitation through kinase design. PNAS 106(3), 667-668 (2009).
8. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm - Cervical Mucus Interaction (4th Edition). Cambridge University Press, Cambridge, UK (1999).
9. Carruthers M, Trinick TR, Jankowska E, Traish AM. Are the adverse effects of glitazones linked to induced testosterone deficiency? Cardiovasc. Diabetol. 7, 30 (2008).
10. Price TM, O'Brien SN, Welter BH, George R, Anandjiwala JK. Oestrogen regulation of adipose tissue lipoprotein lipase-possible mechanisms of body fat distribution. Am. J. Obstet. Gynecol. 178, 101-107 (1998).
11. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144(11), 5081-5088 (2003).
12. Singh R, Artaza JN, Taylor WE et al. Testosterone inhibits adipogenic differentiation in 3T3- L1 cells: nuclear translocation of androgen receptor complex with -catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147(1), 141-154 (2006).
13. McTernan PG, Anderson LA, Anwar AJ. Glucocorticoid regulation of P450 aromatase activity in human adipose tissue: gender and site differences. J. Clin. Endocrin. Metab. 87(3), 1327-1336 (2002).
14. Oken E. Gillman MW. Fetal origins of obesity. Obes. Res. 11, 496-506 (2003).
15. Pauli EM, Legro RS, Demers LM, Kunselman AR, Dodson WC, Lee PA. Diminished paternity and gonadal function with increasing obesity in men. Fertil. Steril. 90, 346-351 (2008).
16. Romero-Corral A, Lopez-Jimenez F, Sierra-Johnson J, Somers VK. Differentiating between body fat and lean mass-how should we measure obesity? Nat. Clin. Pract. Endocrinol. Metab. 4, 322-323 (2008).
17. Jensen TK, Andersson AM, Jorgensen N et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil. Steril. 82, 863-870 (2004).
18. Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW. Male obesity and alteration in sperm parameters. Fertil. Steril. 90(6), 2222-2225 (2008).
19. Kort HI, Massey JB, Elsner CW et al. Impact of body mass index values on sperm quantity and quality. J. Androl. 27, 450-452 (2006).
20. Koloszár S, Fejes I, Závaczki Z, Daru J, Szöllosi J, Pál A. Effect of body weight on sperm concentration in normozoospermic males. Arch. Androl. 51, 299-304 (2005).
21. Hofny ER, Ali ME, Abdel-Hafez HZ et al. Semen parameters and hormonal profile in obese fertile and infertile males. Fertil. Steril. DOI: 10.1016/j.fertstert.2009.03.085 (2009) (Epub ahead of print).
22. Aggerholm AS, Thulstrup AM, Toft G, Ramlau-Hansen CH, Bonde JP. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil. Steril. 90, 619-626 (2008).
23. Duits FH, van Wely M, van der Veen F, Gianotten J. Healthy overweight male partners of subfertile couples should not worry about their semen quality. Fertil. Steril. DOI: 10.1016/j.fertnstert. 2009.05.075 (2009) (Epub ahead of print).
24. Nicopoulou SC, Alexiou M, Michalakis K et al. Body mass index vis-à-vis total sperm count in attendees of a single andrology clinic. Fertil. Steril. 92(3), 1016-1017 (2009).
25. Ramlau-Hansen CH, Thulstrup AM, Nohr EA, Bonde JP, Sørensen TI, Olsen J. Subfecundity in overweight and obese couples. Hum. Reprod. 22(6), 1634-1637 (2007).
26. Sallmén M, Sandler DP, Hoppin JA, Blair A, Baird DD. Reduced fertility among overweight and obese men. Epidemiol. 17(5), 520-523 (2006).
27. Nguyen RH, Wilcox AJ, Skjaerven R, Baird DD. Men's body mass index and infertility. Human Reprod. 22(9), 2488-2493 (2007).
28. Fejes I, Koloszar S, Zavackcski Z, Daru J, Szollosi J, Pal A. Effect of body weight on testosterone/estradiol ratio in olgozoospermic patients. Arch. Androl. 52, 97-102 (2006).
29. Zorn B, Osredkar J, Meden-Vrtovec H, Majdic G. Leptin levels in infertile male patients are correlated with inhibin B, testosterone and SHBG but not with sperm characteristics. Int. J. Androl. 30, 439-444 (2007).
30. Kley HK, Solbach HG, McKinnan JC, Krüskemper HL. Testosterone decrease and estrogen increase in male patients with obesity. Acta Endocrinol. 91, 553-563, (1979).
31. Zumoff B, Strain GW, Miller LK et al. Plasma free and non-SHBG-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 71, 929-931 (1990).
32. Strain GW, Zumoff B, Miller LK et al. Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men. J. Clin. Endocrinol. Metab. 66, 1019-1023 (1988).
33. Zumoff B, Strain GW. A perspective on the hormonal abnormalities of obesity: are they cause or effect? Obes. Res. 2, 56-67, (1994).
34. Schneider G, Kirschner MA, Berkowitz R, Ertel NH. Increased estrogen production in obese men. J. Clin. Endocrinol. Metab. 48, 633-638 (1979).
35. Zumoff B, Strain GW, Kream J, O'Connor J, Levin J, Fukushima DK. Obese young men have elevated plasma estrogen levels, but obese premenopausal women do not. Metabolism 30, 1011-1014 (1981).
36. Strain GW, Zumoff B, Kream J et al. Mild hypogonadotropic hypogonadism in obese men. Metabolism 31, 871-875 (1982).
37. Jung A, Schuppe HC. Influence of genital heat stress on semen quality in humans. Andrologia 39(6), 203-215 (2007).
38. Gat Y, Zukerman Z, Chakraborty J, Gornish M. Varicocele, hypoxia and male infertility. Fluid mechanics analysis of the impaired testicular venous drainage system. Hum. Reprod. 20(9), 2614-2619 (2005).
39. Petak SM, Nankin HR, Spark RF et al. American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Endocr. Pract. 8, 439-456 (2002).
40. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-a(ERa) and estrogen receptor-b (ERb) messenger ribonucleic acid in the wild-type and ERa-knockout mouse. Endocrinology 138, 4613-4621 (1997).
41. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERaand ERb) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36, 357-378 (1998).
42. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-aand -b mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525 (1997).
43. Strain GW, Zumoff B. The effect of bariatric surgery on the abnormalities of the pituitary-gonadal axis in obese men. Surg. Obes. Relat. Dis. 2(2), 75-77 (2006).
44. Cohen PG. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt - a major factor in the genesis of morbid obesity. Med. Hypotheses 52(1), 49-51 (1999).
45. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 80, 239-243 (1995).
46. Kapoor D, Channer KS, Jones TH. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with Type 2 diabetes. Diabetes Vasc. Dis. Res. 5(2), 135-137 (2008).
47. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic- atherogenic-disease and aging connection. Med. Hypotheses 56(6), 702-708 (2001).
48. Hammoud AO, Gibson, M, Hunt SC, Carrell D, Adamas TD, Meikle W. Effect of weight loss after Roux-en-Y gastric bypass surgery on the male reproductive hormonal profile. Fertil. Steril. 88, S1-S2 (2007)
49. Roth MY, Amory JK, Page ST. Treatment of male infertility secondary to morbid obesity. Nat. Clin. Pract. Endocrinol. Metab. 4, 415-419 (2008).
50. de Boer H, Verschoor L, Ruinemans- Koerts J, Jansen M. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes. Metab. 7, 211-215 (2005).
51. Bierman EL, Bagdade JD, Porte D Jr. Obesity and diabetes: the odd couple. Am. J. Clin. Nutr. 21(12), 1434-1437 (1968).
52. Pasquali R, Casimirri F, De Iasio R et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J. Clin. Endocrinol. Metab. 80(2), 654-658 (1995)
53. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 143, 889-897 (1996).
54. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of Type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23, 490-494 (2000).
55. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL; Rancho Bernardo Study. Endogenous sex hormones and the development of Type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25, 55-60 (2002).
56. Laaksonen DE, Niskanen L, Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5), 1036-1041 (2004).
57. Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes. Metab. 6(3), 208-215 (2004).
58. Laaksonen DE, Niskanen L, Punnonen K et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur. J. Endocrinol. 149(6), 601-608 (2003).
59. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older men with diabetes mellitus. Am. J. Epidem. 132, 895-901 (1990).
60. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 17, 405-411 (1994).
61. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in Type 2 diabetes. J. Clin. Endocrin. Met. 89, 5462-5468 (2004).
62. Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 27, 861-868 (2004).
63. Osuna JA, Gomez-Perez R, Arata- Bellabarba G, Villaroel V. Relationship between BMI, total testosterone, sex hormone binding-globulin, leptin, insulin and insulin resistance in obese men. Arch. Androl. 52, 355-361 (2006).
64. Yeap BB, Chubb SA, Hyde Z et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur. J. Endocrinol. 161, 591-598 (2009).
65. Pitteloud N, Mootha VK, Dwyer AA et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28, 1636-1642 (2005).
66. Pitteloud N, Hardin M, Dwyer AA et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J. Clin. Endocrinol. Metab. 90, 2636-2641 (2005).
67. Lin T, Vinson N, Terracio L. Characterization of insulin and insulin-like growth factor receptors in purified Leydig cells and their role in steroidogenesis in primary culture: a comparative study. Endocrinology 119, 1641-1647 (1986).
68. Bebakar WM, Honour JW, Foster D, Liu YL, Jacobs HS. Regulation of testicular function by insulin and transforming growth factor-b. Steroids 55, 266-269 (1990).
69. Burcelin R, Thorens B, Glauser M, Gaillard RC, Pralong FP. Gonadotropin-releasing hormone secretion from hypothalamic neurons stimulation by insulin and potentiation by leptin. Endocrinology 144, 4484-4491 (2003).
70. Echavarría Sánchez MG, Franco Laguna E, Juárez Bengoa A, Villanueva Díaz CA. Seminal quality and hormones in patients with diabetes mellitus Type 2. Ginecol. Obstet. Mex. 75, 241-246 (2007).
71. Ali ST, Shaikh RN, Siddiqi NA, Siddiqi PQ. Semen analysis in insulin-dependent/ non-insulin-dependent diabetic men with/ without neuropathy. Arch. Androl. 30, 47-54 (1993).
72. Vignon F, Le Faou A, Montagnon D et al. Comparative study of semen in diabetic and healthy men. Diabetes Metab. 17, 350-354 (1991).
73. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994).
74. Lee GH, Proenca R, Montez JM et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635 (1996).
75. Wang MY, Zhou YT, Newgard CB, Unger, RH. A novel leptin receptor isoform in rat. FEBS Lett. 392, 87-90 (1998).
76. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 393(Pt 1), 7-20 (2006).
77. Tartaglia LA. The leptin receptor. J. Biol. Chem. 272(10), 6093-6096 (1997).
78. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem. Biophys. Res. Commun. 283(4), 982-988 (2001).
79. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269(5223), 543-546 (1995).
80. Tena-Sempere M, Barreiro ML. Leptin in male reproduction: the testis paradigm. Mol. Cell. Endocrinol. 188(1-2), 9-13 (2002).
81. Cohen P, Zhao C, Cai X et al. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 1113-1121 (2001).
82. Chua SC, Chung WK, Wu-Peng XS et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271, 994-996 (1996).
83. Gibson WT, Farooqi IS, Moreau M et al. Congenital leptin deficiency due to homozygosity for the d133G mutation: report of another case and evaluation of response to four years of leptin therapy. J. Clin. Endocrinol. Metab. 89(10), 4821-4826 (2004).
84. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18, 213-215 (1998).
85. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84(10), 3686-3695 (1999).
86. Mazen I, El-Gammal M, Abdel-Hamid M, Amr K. A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Mol. Genet. Metab. 97(4), 305-308 (2009).
87. Farooqi IS, Wangensteen T, Collins S et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N. Engl. J. Med. 356(3), 237-247 (2007).
88. Farooqi IS, Jebb SA, Langmack G et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879-884 (1999).
89. Farooqi IS, Matarese G, Lord GM et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/ metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103 (2002).
90. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 26, 1407-1433 (2002).
91. Isidori A, Fabbri A. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J. Clin. Endocrinol. Metab. 84, 3673-3680 (1999).
92. Vettor R, De Pergola G, Pagano C et al. Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur. J. Clin. Invest. 27, 1016-1024 (1997).
93. Zorn B, Osredkar J, Meden-Vrtovec H, Majdic G. Leptin levels in infertile male patients are correlated with inhibin B, testosterone and SHBG but not with sperm characteristics. Int. J. Androl. 30(5), 439-444 (2007).
94. Hanafy S, Halawa FA, Mostafa T, Mikhael NW, Khalil KT. Serum leptin correlates in infertile oligozoospermic males. Andrologia 39(5), 177-180 (2007).
95. Caro JF, Kolaczynski JW, Nyce MR et al. Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348(9021), 159-161 (1996).
96. Jéquier E. Leptin signaling, adiposity, and energy balance. Ann. NY Acad. Sci. 967, 379-388 (2002).
97. Couce ME, Green D, Brunetto A, Achim C, Lloyd RV, Burguera B. Limited brain access for leptin in obesity. Pituitary 4(1-2), 101-110 (2001).
98. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 17(2), 305-311 (1996).
99. Banks WA. The blood-brain barrier as a cause of obesity. Curr. Pharm. Des. 14(16), 1606-1614 (2008).
100. Wong ML, Licinio J, Yildiz BO et al. Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: dissociation of concentrations in central and peripheral compartments. J. Clin. Endocrinol. Metab. 89(1), 258-265 (2004).
101. Kalra SP. Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 29(1), 127-138 (2008).
102. Cunningham MJ, Clifton DK, Steiner RA. Leptin's actions on the reproductive axis: perspectives and mechanisms. Biol. Reprod. 60(2), 216-222 (1999).
103. Sweeney, G. Leptin signalling. Cell. Signall. 14, 655-663 (2002).
104. Mounzih K, Lu R, Chehab FF. Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 138(3), 1190-1193 (1997).
105. Cleary MP, Bergstrom HM, Dodge TL, Getzin SC, Jacobson MK, Phillips FC. Restoration of fertility in young obese (Lep(ob) Lep(ob)) male mice with low dose recombinant mouse leptin treatment. Int. J. Obes. Relat. Metab. Disord. 25(1), 95-97 (2001).
106. Gottsch ML, Cunningham MJ, Smith JT et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145(9), 4073-4077 (2004).
107. Kotani M, Detheux M, Vandenbogaerde A et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 276(37), 34631-34636 (2001).
108. Tena-Sempere M. GPR54 and kisspeptin in reproduction. Hum. Reprod. Update 12(5), 631-639 (2006).
109. Smith JT, Acohido BV, Clifton DK, Steiner RA. KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J. Neuroendocrinol. 18(4), 298-303 (2006).
110. Quennell JH, Mulligan AC, Tups A et al. Leptin indirectly regulates gonadotropin-releasing hormone neuronal function. Endocrinology 150(6), 2805-2812 (2009).
111. Tapanainen JS, Tilly JL, Vihko KK, Hsueh AJW. Hormonal control of apoptotic cell death in the testis: gonadotropins and androgens as testicular cell survival factors. Mol. Endocrinol. 7, 643-650 (1993).
112. Sinha Hikim AP, Swerdloff RS. Hormonal and genetic control of germ cell apoptosis in the testis. Rev. Reprod. 4(1), 38-47 (1999).
113. Yan W, Samson M, Jégou B, Toppari J. Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol. Endocrinol. 14(5), 682-699 (2000).
114. Sofikitis N, Giotitsas N, Tsounapi P, Baltogiannis D, Giannakis D, Pardalidis N. Hormonal regulation of spermatogenesis and spermiogenesis. J. Steroid Biochem. Mol. Biol. 109(3-5), 323-330 (2008).
115. Bhat GK, Sea TL, Olatinwo MO et al. Influence of a leptin deficiency on testicular morphology, germ cell apoptosis, and expression levels of apoptosis-related genes in the mouse. J. Androl. 27(2), 302-310 (2006).
116. Lee J, Richburg JH, Younkin SC, Boekelheide K. The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology 138, 2081-2088 (1997).
117. Ishikawa T, Fujioka H, Ishimura T, Takenaka A, Fujisawa M. Expression of leptin and leptin receptor in the testis of fertile and infertile patients. Andrologia 39, 22-27 (2007).
118. Herrid M, O'Shea T, McFarlane JR. Ontogeny of leptin and its receptor expression in mouse testis during the postnatal period. Mol. Reprod. Dev. 75(5), 874-880 (2008).
119. Banks WA, McLay RN, Kastin AJ, Sarmiento U, Scully S. Passage of leptin across the blood-testis barrier. Am. J. Physiol. 276, E1099-E1104 (1999).
120. El-Hefnawy T, Ioffe S, Dym M. Expression of the leptin receptor during germ cell development in the mouse testis. Endocrinology 141, 2624-2630 (2000).
121. Caprio M, Fabbrini E, Ricci G et al. Ontogenesis of leptin receptor in rat Leydig cells. Biol. Reprod. 68(4), 1199-1207 (2003).
122. Tena-Sempere M, Pinilla L, Zhang FP et al. Developmental and hormonal regulation of leptin receptor (Ob-R) messenger ribonucleic acid expression in rat testis. Biol. Reprod. 64, 634-643 (2001).
123. Glander HJ, Lammert A, Paasch U, Glasow A, Kratzsch J. Leptin exists in tubuli seminiferi and in seminal plasma. Andrologia 34, 227-233 (2002).
124. Cioffi JA, Shafer AW, Zupancic TJ et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat. Med. 2, 585-589 (1996).
125. O'Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr. Rev. 22, 289-318 (2001).
126. Caprio M, Isidori AM, Carta AR, Moretti C, Dufau ML, Fabbri A. Expression of functional leptin receptors in rodent Leydig cells. Endocrinology 140, 4939-4947 (1999).
127. Herrid M, Xia Y, O'Shea T, McFarlane JR. Leptin inhibits basal but not gonadotrophin-stimulated testosterone production in the immature mouse and sheep testis. Reprod. Fertil. Dev. 20(4), 519-528 (2008).
128. Tena-Sempere M, Pinilla L, Gonzalez LC, Dieguez C, Casanueva FF, Aguilar E. Leptin inhibits testosterone secretion from adult rat testis in vitro. J. Endocrinol. 161, 211-218 (1999).
129. Tena-Sempere M, Pinilla L, González LC et al. In vitro pituitary and testicular effects of the leptin-related synthetic peptide leptin(116-130) amide involve actions both similar to and distinct from those of the native leptin molecule in the adult rat. Eur. J. Endocrinol. 142(4), 406-410 (2000).
130. Ahima RS, Osei SY. Leptin signaling. Physiol. Behav. 81, 223-241(2004).
131. Bjørbæck C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272, 32686-32695 (1997).
132. Bjørbæck C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Rec. Prog. Horm. Res. 59, 305-331 (2004).
133. Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 11, 393-399 (1997).
134. Aquila S, Rago V, Guido C, Casaburi I, Zupo S, Carpino A. Leptin and leptin receptor in pig spermatozoa: evidence of their involvement in sperm capacitation and survival. Reproduction 136(1), 23-32 (2008).
135. Ruiz-Cortés ZT, Martel-Kennes Y, Gévry NY, Downey BR, Palin MF, Murphy BD. Biphasic effects of leptin in porcine granulosa cells. Biol. Reprod. 68(3), 789-796 (2003).
136. Stocco DM, Wang X, Jo Y, Manna PR. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol. Endocrinol. 19(11), 2647-2659 (2005).
137. Matsuda T, Nakamura T, Nakao K et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18(15), 4261-4269 (1999).
138. Tena-Sempere M, Pinilla L, Zhang FP et al. Developmental and hormonal regulation of leptin receptor (Ob-R) messenger ribonucleic acid expression in rat testis. Biol. Reprod. 64(2), 634-643 (2001).
139. von Sobbe HU, Koebnick C, Jenne L, Kiesewetter F. Leptin concentrations in semen are correlated with serum leptin and elevated in hypergonadotrophic hypogonadism. Andrologia 35(4), 233-237 (2003).
140. Ando S, Aquila S. Arguments raised by the recent discovery that insulin and leptin are expressed in and secreted by human ejaculated spermatozoa. Mol. Cell. Endocrinol. 245, 1-6 (2005).
141. Aquila S, Gentile M, Middea E et al. Leptin secretion by human spermatozoa. J. Clin. Endocrinol. Metab. 90, 4753-4761 (2005).
142. Chen B, Guo JH, Lu YN et al. Leptin and varicocele-related spermatogenesis dysfunction: animal experiment and clinical study. Int. J. Androl 32(5), 532-541 (2008).
143. Visconti PE, Bailey JL, Moore GD, Pan D, Olds-Clarke P, Kopf GS. Capacitation of mouse spermatozoa. I. Correlation between the capacitation state and protein tyrosine phosphorylation. Development 121, 1129-1137 (1995).
144. De Ambrogi M, Spinaci M, Galeati G, Tamanini C. Leptin receptor in boar spermatozoa. Int. J. Androl. 30, 458-461 (2007).
145. Li HW, Chiu PC, Cheung MP, Yeung WS, O WS. Effect of leptin on motility, capacitation and acrosome reaction of human spermatozoa. Int. J. Androl. 32(6), 687-694 (2008).
146. Jope T, Lammert A, Kratzsch J, Paasch U, Glander HJ. Leptin and leptin receptor in human seminal plasma and in human spermatozoa. Int. J. Androl. 26, 335-341 (2003).
147. Hjollund NH, Storgaard L, Ernst E, Bonde JP, Olsen J. Impact of diurnal scrotal temperature on semen quality. Reprod. Toxicol. 16(3), 215-221 (2002).
148. Jung A, Schill WB, Schuppe HC. Genital heat stress in men of barren couples: a prospective evaluation by means of a questionnaire. Andrologia 34(6), 349-355 (2002).
149. Carlsen E, Andersson AM, Petersen JH, Skakkebaek NE. History of febrile illness and variation in semen quality. Hum. Reprod. 18(10), 2089-2092 (2003).
150. Hjollund NH, Bonde JP, Jensen TK, Olsen J. Diurnal scrotal skin temperature and semen quality. The Danish First Pregnancy Planner Study Team. Int. J. Androl. 23(5), 309-318 (2000).
151. Hjollund NH, Storgaard L, Ernst E, Bonde JP, Olsen J. The relation between daily activities and scrotal temperature. Reprod. Toxicol. 16(3), 209-214 (2002).
152. Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, Heimisdottir M, Olafsdottir K. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum. Reprod. 20(1), 208-215 (2005).
153. Lue YH, Hikim AP, Swerdloff RS et al. Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity. Endocrinology 140, 1709-1717 (1999).
154. Paul C, Melton DW, Saunders PT. Do heat stress and deficits in DNA repair pathways have a negative impact on male fertility? Mol. Hum. Reprod. 14(1), 1-8 (2008).
155. Paul C, Teng S, Saunders PT. A single, mild, transient scrotal heat stress causes hypoxia and oxidative stress in mouse testes, which induces germ cell death. Biol. Reprod 80(5), 913-919 (2009).
156. Yin Y, Hawkins KL, DeWolf WC, Morgentaler A. Heat stress causes testicular germ cell apoptosis in adult mice. J. Androl. 18(2), 159-165 (1997).
157. Zhu BK, Setchell BP. Effects of paternal heat stress on the in vivo development of preimplantation embryos in the mouse. Reprod. Nut. Dev. 44, 617-629 (2004).
158. Cammack KM, Mesa H, Lamberson WR. Genetic variation in fertility of heat-stressed male mice. Theriogenology 66, 2195-2201 (2006).
159. Eddy EM. Role of heat shock protein HSP70-2 in spermatogenesis. Rev. Reprod. 4(1), 23-30 (1999).
160. Georgopoulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu. Rev. Cell. Biol. 9, 601-634 (1993).
161. Vydra N, Malusecka E, Jarzab M et al. Spermatocyte-specific expression of constitutively active heat shock factor 1 induces HSP70i-resistant apoptosis in male germ cells. Cell Death Differ. 13(2), 212-222 (2006).
162. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell. Biol. 17(9), 5317-5327 (1997).
163. Rockett JC, Mapp FL, Garges JB, Luft JC, Mori C, Dix DJ. Effects of hyperthermia on spermatogenesis, apoptosis, gene expression, and fertility in adult male mice. Biol. Reprod. 65, 229-239 (2001).
164. Izu H, Inouye S, Fujimoto M, Shiraishi K, Naito K, Nakai A. Heat shock transcription factor 1 is involved in quality-control mechanisms in male germ cells. Biol. Reprod. 70, 18-24 (2004).
165. Fernandes M, Xiao H, Lis JT. Fine structure analyses of the Drosophila and Saccharomyces heat shock factor - heat shock element interactions. Nucleic Acids Res. 22(2), 167-173 (1994).
166. Salmand PA, Jungas T, Fernandez M, Conter A, Christians ES. 2008 Mouse heat-shock factor 1 (HSF1) is involved in testicular response to genotoxic stress induced by doxorubicin. Biol. Reprod. 79(6), 1092-1101.
167. Widlak W, Winiarski B, Krawczyk A, Vydra N, Malusecka E, Krawczyk Z. Inducible 70 kDa heat shock protein does not protect spermatogenic cells from damage induced by cryptorchidism. Int. J. Androl. 30(2), 80-87 (2007).
168. Tramontano F, Malanga M, Farina B, Jones R, Quesada P. Heat stress reduces poly(ADPR)polymerase expression in rat testis. Mol. Hum. Reprod. 6(7), 575-581 (2000).
169. Jia Y, Castellanos J, Wang C et al. Mitogen-activated protein kinase signaling in male germ cell apoptosis in the rat. Biol. Reprod. 80(4), 771-780 (2009).
170. Johnson C, Jia Y, Wang C et al. Role of caspase 2 in apoptotic signaling in primate and murine germ cells. Biol. Reprod. 79(5), 806-814 (2008).
171. Krumschnabel G, Sohm B, Bock F, Manzl C, Villunger A. The enigma of caspase-2: the laymen's view. Cell. Death Differ. 16(2), 195-207 (2009).
172. Weidemann A, Johnson RS. Biology of HIF-1a. Cell. Death Differ. 15, 621-627 (2008).
173. Setchell BP. The Parkes Lecture. Heat and the testis. J. Reprod. Fert. 114, 179-194 (1998).
174. Paul C, Murray AA, Spears N, Saunders PT. A single, mild, transient scrotal heat stress causes DNA damage, subfertility and impairs formation of blastocysts in mice. Reproduction 136(1), 73-84 (2008).
175. Carlsen E, Giwereman A, Keiding N, Skakkebaek NE. Evidence for decreasing sperm quality of semen during the past 50 years. Br. Med. J. 304, 609-613 (1992).
176. US Environmental Protection Agency. Special Report on Environmental Endocrine Disruption: an Effects Assessment and Analysis. Office of Research and Development. Washington, DC, USA, EPA/630/R-96/012 (1997).
177. WHO. Global assessment of the state-of-the-sience of endocrine disruptors. International Programme on Chemical Safety. Damstra T, Barlow S, Bergman A, Kavlock R, Van Der Kraak G (Eds). WHO, Geneva, Switzerland (2002).
178. Phillips KP, Tanphaichitr N. Human exposure to endocrine disrupters and semen quality. J. Toxicol. Environ. Health B Crit. Rev. 11(3-4), 188-220 (2008).
179. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Comp. Med. 8, 185-192 (2002).
180. Newbold R, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod. Toxicol. 23, 290-296 (2007).
181. Newbold R, Padilla-Banks E, Snyder RJ, Jefferson WN. Perinatal exposure to environmental estrogens and the development of obesity. Mol. Nut. Food Res. 51, 912-917 (2007).
182. Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int. J.Epidemiol. 31, 1235-1239 (2002).
183. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Ped. Res. 56, 311-317 (2004).
184. Hanson M, Gluckman P, Bier D et al. Report on the 2nd World Congress on Fetal Origins of Adult Disease, Brighton, UK, June 7-10, 2003. Ped. Res. 55, 894-897 (2004).
185. Pryor JL, Hughes C, Foster W, Hales BF, Robaire B. Critical windows of exposure for children's health: the reproductive system in animals and humans. Environ. Health Perspect. 108, 491-503 (2000).
186. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972-978 (2001).
187. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ. Effects of endocrine disruptors on obesity. Int. J. Androl. 31(2), 201-208 (2008).
188. Goyal HO, Braden TD, Williams CS et al. Abnormal morphology of the penis in male rats exposed neonatally to diethylstilbestrol is associated with altered profile of estrogen receptor-a protein, but not of androgen receptor protein: a developmental and immunocytochemical study. Biol. Reprod. 70, 1504-1517 (2004).
189. Goyal HO, Braden TD, Williams CS, Dalvi P, Mansour MM, Williams JW. Permanent induction of morphological abnormalities in the penis and penile skeletal muscles in adult rats treated neonatally with diethylstilbestrol or estradiol valerate: a dose-response study. J. Androl. 26, 32-43 (2005).
190. Goyal HO, Braden TD, Williams CS, Dalvi P, Mansour M, Williams JW. Estrogen-induced abnormal accumulation of fat cells in the rat penis and associated loss of fertility depends upon estrogen exposure during critical period of penile development. Toxicol. Sci. 87(1), 242-254 (2005).
191. Goyal HO, Braden TD, Cooke PS et al. Estrogen receptor amediates estrogen-inducible abnormalities in the developing penis. Reprod. 133(5), 1057-1067 (2007).
192. Mansour MM, Goyal HO, Braden TD et al. Activation of penile proadipogenic peroxisome proliferator-activated receptor gwith an estrogen: interaction with estrogen receptor aduring postnatal development. PPAR Res. 2008, 651419 (2008).
193. Li D, Kang Q, Wang DM. Constitutive coactivator of peroxisome proliferator-activated receptor (PPARg), a novel coactivator of PPARgthat promotes adipogenesis. Mol. Endocrinol. 21(10), 2320-2333 (2007).
194. Keller H, Givel F, Perroud M, Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol. 9(7), 794-804 (1995).
195. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA 93(12), 5925-5930 (1996).
196. Kuiper GG, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors aand b. Endocrinology 138(3), 863-870 (1997).
197. Kraus WL, Weis KE, Katzenellenbogen BS. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell. Biol. 15(4), 1847-1857 (1995).
198. Feige JN, Gelman L, Rossi D et al. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gmodulator that promotes adipogenesis. J. Biol. Chem. 282(26), 19152-19166 (2007).
199. Grün F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocr. Metab. Disord. 8(2), 161-171 (2007).
200. Grün F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147, S50-S55 (2006).
201. Müllerová D, Kopecki J. White adipose tissue: storage and effector site for environmental pollutants. Physiol. Res. 56(4), 375-381 (2007).
202. Ryu JY, Whang J, Park H et al. Di(2- ethylhexyl) phthalate induces apoptosis through peroxisome proliferators-activated receptor-gand ERK 1/2 activation in testis of Sprague-Dawley rats. J. Toxicol. Environ. Health A. 70(15-16), 1296-1303 (2007).
203. Matthiessen P, Gibbs P. Critical appraisal of the evidence for tributyltinmediated endocrine disruption in mollusks. Environ. Toxicol. Chem. 17, 37-43 (1998).
204. Grün F, Watanabe H, Zamanian Z et al. Endocrine disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol. 20, 2141-2155 (2006).
205. Tabb MM, Blumberg B. New modes of action for endocrine-disrupting chemicals. Mol. Endocrinol. 20(3), 475-482 (2006).
206. Nakanishi T. Endocrine disruption induced by organotin compounds: organotin's function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor. J. Toxicol. Sci. 33(3), 269-276 (2008).
207. Remillard RB, Bunce NJ. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ. Health Perspect. 110(9), 853-858 (2002).
208. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CW. Peroxisome proliferator-activated receptor g(PPAR g) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem. 278, 962-967 (2003).
209. Phillips KP, Foster WG. Key developments in endocrine disrupter research and human health. J. Toxicol. Environ. Health B Crit. Rev. 11(3-4), 322-344 (2008).